{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:10Z","timestamp":1792782850415,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["20154JRJPP"],"award-info":[{"award-number":["20154JRJPP"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNCCS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00726-019-02731-4","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T06:07:13Z","timestamp":1556518033000},"page":"247-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism"],"prefix":"10.1007","volume":"52","author":[{"given":"Gianni","family":"Colotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saccoliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gramiccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trentina","family":"Di Muccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Vistoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasia","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Noemi","family":"Madia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Messore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Costi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-399X","authenticated-orcid":false,"given":"Andrea","family":"Ilari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"2731_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1432-1033.1993.tb17734.x","volume":"213","author":"S Bailey","year":"1993","unstructured":"Bailey S, Smith K, Fairlamb AH, Hunter WN (1993) Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution. Eur J Biochem FEBS 213:67\u201375","journal-title":"Eur J Biochem FEBS"},{"key":"2731_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1021\/jm900185q","volume":"52","author":"P Baiocco","year":"2009","unstructured":"Baiocco P, Colotti G, Franceschini S, Ilari A (2009a) Molecular basis of antimony treatment in leishmaniasis. J Med Chem 52:2603\u20132612. \nhttps:\/\/doi.org\/10.1021\/jm900185q","journal-title":"J Med Chem"},{"key":"2731_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/092986609787316306","volume":"16","author":"P Baiocco","year":"2009","unstructured":"Baiocco P, Franceschini S, Ilari A, Colotti G (2009b) Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis. Protein Pept Lett 16:196\u2013200","journal-title":"Protein Pept Lett"},{"key":"2731_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1021\/ml1002629","volume":"2","author":"P Baiocco","year":"2011","unstructured":"Baiocco P, Ilari A, Ceci P, Orsini S, Gramiccia M, Di Muccio T, Colotti G (2011) Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation. ACS Med Chem Lett 2:230\u2013233. \nhttps:\/\/doi.org\/10.1021\/ml1002629","journal-title":"ACS Med Chem Lett"},{"key":"2731_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/cmdc.201300176","volume":"8","author":"P Baiocco","year":"2013","unstructured":"Baiocco P et al (2013) Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography. ChemMedChem 8:1175\u20131183. \nhttps:\/\/doi.org\/10.1002\/cmdc.201300176","journal-title":"ChemMedChem"},{"key":"2731_CR6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.freeradbiomed.2009.08.025","volume":"47","author":"A Bhattacharya","year":"2009","unstructured":"Bhattacharya A, Biswas A, Das PK (2009) Role of a differentially expressed cAMP phosphodiesterase in regulating the induction of resistance against oxidative damage in Leishmania donovani. Free Radic Biol Med 47:1494\u20131506. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.08.025","journal-title":"Free Radic Biol Med"},{"key":"2731_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392:951\u2013970. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2","journal-title":"Lancet"},{"key":"2731_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00726-010-0630-3","volume":"40","author":"G Colotti","year":"2011","unstructured":"Colotti G, Ilari A (2011) Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids 40:269\u2013285. \nhttps:\/\/doi.org\/10.1007\/s00726-010-0630-3","journal-title":"Amino Acids"},{"key":"2731_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.4155\/fmc.13.146","volume":"5","author":"G Colotti","year":"2013","unstructured":"Colotti G, Baiocco P, Fiorillo A, Boffi A, Poser E, Chiaro FD, Ilari A (2013a) Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs. Future Med Chem 5:1861\u20131875. \nhttps:\/\/doi.org\/10.4155\/fmc.13.146","journal-title":"Future Med Chem"},{"key":"2731_CR10","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/cmdc.201300276","volume":"8","author":"G Colotti","year":"2013","unstructured":"Colotti G et al (2013b) Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes. ChemMedChem 8:1634\u20131637. \nhttps:\/\/doi.org\/10.1002\/cmdc.201300276","journal-title":"ChemMedChem"},{"key":"2731_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2741\/4628","volume":"23","author":"G Colotti","year":"2018","unstructured":"Colotti G, Fiorillo A, Ilari A (2018) Metal- and metalloid-containing drugs for the treatment of trypanosomatid diseases. Front Biosci (Landmark Ed) 23:954\u2013966","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2731_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/9783527670383.ch9","volume-title":"Trypanosomatid diseases","author":"MA Comini","year":"2013","unstructured":"Comini MA, Floh\u00e9 L (2013) Trypanothione-based redox metabolism of trypanosomatids. In: J\u00e4ger T, Koch O, Floh\u00e9 L (eds) Trypanosomatid diseases. Wiley-VCH Verlag GmbH & Co. KGaA, Hoboken, pp\u00a0167\u2013199. \nhttps:\/\/doi.org\/10.1002\/9783527670383.ch9"},{"key":"2731_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/095632020001100204","volume":"11","author":"R Costi","year":"2000","unstructured":"Costi R et al (2000) Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase. Antivir Chem Chemother 11:117\u2013133. \nhttps:\/\/doi.org\/10.1177\/095632020001100204","journal-title":"Antivir Chem Chemother"},{"key":"2731_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305\u2013318. \nhttps:\/\/doi.org\/10.1016\/j.cimid.2004.03.004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2731_CR15","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1016\/j.bmc.2005.04.039","volume":"13","author":"MJ Dixon","year":"2005","unstructured":"Dixon MJ, Maurer RI, Biggi C, Oyarzabal J, Essex JW, Bradley M (2005) Mechanism and structure\u2013activity relationships of norspermidine-based peptidic inhibitors of trypanothione reductase. Bioorg Med Chem 13:4513\u20134526. \nhttps:\/\/doi.org\/10.1016\/j.bmc.2005.04.039","journal-title":"Bioorg Med Chem"},{"key":"2731_CR16","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","volume":"16","author":"C Dumas","year":"1997","unstructured":"Dumas C et al (1997) Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J 16:2590\u20132598. \nhttps:\/\/doi.org\/10.1093\/emboj\/16.10.2590","journal-title":"EMBO J"},{"key":"2731_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1042\/BJ20021298","volume":"369","author":"CJ Hamilton","year":"2003","unstructured":"Hamilton CJ, Saravanamuthu A, Eggleston IM, Fairlamb AH (2003) Ellman\u2019s-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase. Biochem J 369:529\u2013537. \nhttps:\/\/doi.org\/10.1042\/BJ20021298","journal-title":"Biochem J"},{"key":"2731_CR18","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.bmc.2005.11.004","volume":"14","author":"CJ Hamilton","year":"2006","unstructured":"Hamilton CJ, Saravanamuthu A, Poupat C, Fairlamb AH, Eggleston IM (2006) Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products. Bioorg Med Chem 14:2266\u20132278. \nhttps:\/\/doi.org\/10.1016\/j.bmc.2005.11.004","journal-title":"Bioorg Med Chem"},{"key":"2731_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.bmcl.2006.11.090","volume":"17","author":"GA Holloway","year":"2007","unstructured":"Holloway GA et al (2007) Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening. Bioorg Med Chem Lett 17:1422\u20131427. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2006.11.090","journal-title":"Bioorg Med Chem Lett"},{"key":"2731_CR20","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1371\/journal.pntd.0001475","volume":"6","author":"PJ Hotez","year":"2012","unstructured":"Hotez PJ, Savioli L, Fenwick A (2012) Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 6:e1475. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0001475","journal-title":"PLoS Negl Trop Dis"},{"key":"2731_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","volume":"42","author":"A Ilari","year":"2012","unstructured":"Ilari A et al (2012) A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition. Amino Acids 42:803\u2013811. \nhttps:\/\/doi.org\/10.1007\/s00726-011-0997-9","journal-title":"Amino Acids"},{"key":"2731_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/138955751503150312141044","volume":"15","author":"A Ilari","year":"2015","unstructured":"Ilari A, Fiorillo A, Baiocco P, Poser E, Angiulli G, Colotti G (2015) Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review. Mini Rev Med Chem 15:243\u2013252","journal-title":"Mini Rev Med Chem"},{"key":"2731_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4155\/fmc-2016-0180","volume":"9","author":"A Ilari","year":"2017","unstructured":"Ilari A, Fiorillo A, Genovese I, Colotti G (2017) Polyamine\u2013trypanothione pathway: an update. Future Med Chem 9:61\u201377. \nhttps:\/\/doi.org\/10.4155\/fmc-2016-0180","journal-title":"Future Med Chem"},{"key":"2731_CR24","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1021\/acs.molpharmaceut.8b00185","volume":"15","author":"A Ilari","year":"2018","unstructured":"Ilari A, Genovese I, Fiorillo F, Battista T, De Ionna I, Fiorillo A, Colotti G (2018) Toward a drug against all kinetoplastids: from leishbox to specific and potent trypanothione reductase inhibitors. Mol Pharm 15:3069\u20133078. \nhttps:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00185","journal-title":"Mol Pharm"},{"key":"2731_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb O, Stutzle T, Exner TE (2009) Empirical scoring functions for advanced protein-ligand docking with Plants. J Chem Inf Model 49:84\u201396. \nhttps:\/\/doi.org\/10.1021\/ci800298z","journal-title":"J Chem Inf Model"},{"key":"2731_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","volume":"1780","author":"RL Krauth-Siegel","year":"2008","unstructured":"Krauth-Siegel RL, Comini MA (2008) Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta 1780:1236\u20131248. \nhttps:\/\/doi.org\/10.1016\/j.bbagen.2008.03.006","journal-title":"Biochim Biophys Acta"},{"key":"2731_CR27","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1016\/S0040-4039(02)01190-5","volume":"43","author":"GL Luo","year":"2002","unstructured":"Luo GL, Chen L, Poindexter GS (2002) Microwave-assisted synthesis of aminopyrimidines. Tetrahedron Lett 43:5739\u20135742. \nhttps:\/\/doi.org\/10.1016\/S0040-4039(02)01190-5","journal-title":"Tetrahedron Lett"},{"key":"2731_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.bmcl.2006.12.016","volume":"17","author":"DC Martyn","year":"2007","unstructured":"Martyn DC, Jones DC, Fairlamb AH, Clardy J (2007) High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Bioorg Med Chem Lett 17:1280\u20131283. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2006.12.016","journal-title":"Bioorg Med Chem Lett"},{"key":"2731_CR29","first-page":"554","volume":"4","author":"SDS Massa","year":"1994","unstructured":"Massa SDS, Costi R, Artico R, Loi M, Doa AG, Scano M, La Colla P (1994) Synthesis of novel HEPT analogues with anti-HIV-1 activity. Med Chem Res 4:554\u2013562","journal-title":"Med Chem Res"},{"key":"2731_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/phrs.1996.0011","volume":"33","author":"R Mukhopadhyay","year":"1996","unstructured":"Mukhopadhyay R, Kapoor P, Madhubala R (1996) Antileishmanial effect of a potent S-adenosylmethionine decarboxylase inhibitor: CGP 40215A. Pharmacol Res 33:67\u201370. \nhttps:\/\/doi.org\/10.1006\/phrs.1996.0011","journal-title":"Pharmacol Res"},{"key":"2731_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molbiopara.2004.10.004","volume":"139","author":"SL Oza","year":"2005","unstructured":"Oza SL, Shaw MP, Wyllie S, Fairlamb AH (2005) Trypanothione biosynthesis in Leishmania major. Mol biochem Parasitol 139:107\u2013116. \nhttps:\/\/doi.org\/10.1016\/j.molbiopara.2004.10.004","journal-title":"Mol biochem Parasitol"},{"key":"2731_CR32","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1021\/jm200312v","volume":"54","author":"S Patterson","year":"2011","unstructured":"Patterson S et al (2011) Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography. J Med Chem 54:6514\u20136530. \nhttps:\/\/doi.org\/10.1021\/jm200312v","journal-title":"J Med Chem"},{"key":"2731_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1093-3263(02)00123-7","volume":"21","author":"A Pedretti","year":"2002","unstructured":"Pedretti A, Villa L, Vistoli G (2002) VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model 21:47\u201349","journal-title":"J Mol Graph Model"},{"key":"2731_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","volume":"32","author":"F Saccoliti","year":"2017","unstructured":"Saccoliti F et al (2017) Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives. J Enzyme Inhib Med Chem 32:304\u2013310. \nhttps:\/\/doi.org\/10.1080\/14756366.2016.1250755","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2731_CR35","doi-asserted-by":"publisher","first-page":"29493","DOI":"10.1074\/jbc.M403187200","volume":"279","author":"A Saravanamuthu","year":"2004","unstructured":"Saravanamuthu A, Vickers TJ, Bond CS, Peterson MR, Hunter WN, Fairlamb AH (2004) Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem 279:29493\u201329500. \nhttps:\/\/doi.org\/10.1074\/jbc.M403187200","journal-title":"J Biol Chem"},{"key":"2731_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ejpb.2013.08.014","volume":"85","author":"P Saudagar","year":"2013","unstructured":"Saudagar P, Saha P, Saikia AK, Dubey VK (2013) Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen. Eur J Pharm Biopharm 85:569\u2013577. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2013.08.014","journal-title":"Eur J Pharm Biopharm"},{"key":"2731_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s004360050272","volume":"83","author":"D Sereno","year":"1997","unstructured":"Sereno D, Lemesre JL (1997) Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro. Parasitol Res 83:401\u2013403","journal-title":"Parasitol Res"},{"key":"2731_CR38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/cmdc.200900262","volume":"4","author":"D Spinks","year":"2009","unstructured":"Spinks D et al (2009) Investigation of trypanothione reductase as a drug target in Trypanosoma brucei. ChemMedChem 4:2060\u20132069. \nhttps:\/\/doi.org\/10.1002\/cmdc.200900262","journal-title":"ChemMedChem"},{"key":"2731_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","volume":"19","author":"JJ Stewart","year":"2013","unstructured":"Stewart JJ (2013) Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters. J Mol Model 19:1\u201332. \nhttps:\/\/doi.org\/10.1007\/s00894-012-1667-x","journal-title":"J Mol Model"},{"key":"2731_CR40","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1039\/b806371k","volume":"6","author":"B Stump","year":"2008","unstructured":"Stump B, Eberle C, Kaiser M, Brun R, Krauth-Siegel RL, Diederich F (2008) Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities. Org Biomol Chem 6:3935\u20133947. \nhttps:\/\/doi.org\/10.1039\/b806371k","journal-title":"Org Biomol Chem"},{"key":"2731_CR41","doi-asserted-by":"publisher","first-page":"e0006969","DOI":"10.1371\/journal.pntd.0006969","volume":"12","author":"L Turcano","year":"2018","unstructured":"Turcano L et al (2018) Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl Trop Dis 12:e0006969. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0006969","journal-title":"PLoS Negl Trop Dis"},{"key":"2731_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1021\/acs.jcim.7b00121","volume":"57","author":"G Vistoli","year":"2017","unstructured":"Vistoli G, Mazzolari A, Testa B, Pedretti A (2017) Binding space concept: a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity. J Chem Inf Model 57:1691\u20131702. \nhttps:\/\/doi.org\/10.1021\/acs.jcim.7b00121","journal-title":"J Chem Inf Model"},{"key":"2731_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1476-5381.2010.00704.x","volume":"160","author":"EA Wintner","year":"2010","unstructured":"Wintner EA et al (2010) A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160:941\u2013957. \nhttps:\/\/doi.org\/10.1111\/j.1476-5381.2010.00704.x","journal-title":"Br J Pharmacol"},{"key":"2731_CR44","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","volume":"22","author":"B Zulfiqar","year":"2017","unstructured":"Zulfiqar B, Shelper TB, Avery VM (2017) Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discov Today 22:1516\u20131531. \nhttps:\/\/doi.org\/10.1016\/j.drudis.2017.06.004","journal-title":"Drug Discov Today"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-019-02731-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-019-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T19:20:04Z","timestamp":1588015204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-019-02731-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1007\/s00726-019-02731-4","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}